Clinical Trials Browser

HER2-negative Breast Cancer × Vinorelbine × Clear all

NCT06102824 2024-11-25

ORIENTA

Phase 2 Recruiting

HER2-negative Breast Cancer

NCT04848454 2022-10-18

Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy

Phase 2 Unknown

HER2-negative Breast Cancer